Feedback of results to trial participants: be upfront or risk affront

Affiliations

¹ Department of Gastrosurgical Research, Institute of Clinical Sciences, Gothenburg University, Gothenburg 41345, Sweden; Research Department, The Royal College of Surgeons of England, London, UK. Electronic address: beamishaj@gmail.com.
² Research Department, The Royal College of Surgeons of England, London, UK; General Surgery Specialty Training Programme, Severn Deanery, Bristol, UK.
³ Cincinnati Children's Hospital and Medical Center, Cincinnati, OH, USA.

Comment

Andrew J Beamish et al. Lancet. 2017.

. 2017 Mar 25;389(10075):1191-1192.

doi: 10.1016/S0140-6736(17)30778-X.

¹ Department of Gastrosurgical Research, Institute of Clinical Sciences, Gothenburg University, Gothenburg 41345, Sweden; Research Department, The Royal College of Surgeons of England, London, UK. Electronic address: beamishaj@gmail.com.
² Research Department, The Royal College of Surgeons of England, London, UK; General Surgery Specialty Training Programme, Severn Deanery, Bristol, UK.
³ Cincinnati Children's Hospital and Medical Center, Cincinnati, OH, USA.

No abstract available

Comment on

Closure of mesenteric defects in laparoscopic gastric bypass: a multicentre, randomised, parallel, open-label trial.
Stenberg E, Szabo E, Ågren G, Ottosson J, Marsk R, Lönroth H, Boman L, Magnuson A, Thorell A, Näslund I. Stenberg E, et al. Lancet. 2016 Apr 2;387(10026):1397-1404. doi: 10.1016/S0140-6736(15)01126-5. Epub 2016 Feb 16. Lancet. 2016. PMID: 26895675 Clinical Trial.